Anas Shamsi

发表

Insight into the Biological Roles and Mechanisms of Phytochemicals in Different Types of Cancer: Targeting Cancer Therapeutics

A. Alsayari, A. B. Muhsinah, A. Atiya, 2023, Nutrients.

Therapeutic Targeting of Regulated Signaling Pathways of Non-Small Cell Lung Carcinoma

G. Hasan, S. Sohal, Manzar Alam, 2023, ACS omega.

Structure-guided identification of potent inhibitors of ROS1 kinase for therapeutic development against non-small cell lung cancer.

M. Khan, N. Altwaijry, N. Alafaleq, 2023, Journal of biomolecular structure & dynamics.

Investigating the Effect of Cigarette Smoking on Serum Uric Acid Levels in Multiple Sclerosis Patients: A Cross Sectional Study

C. Constantinescu, A. Manouchehrinia, B. Gran, 2023, Brain sciences.

Identifying β-secretase 1 (BACE1) inhibitors from plant-based compounds: an approach targeting Alzheimer’s therapeutics employing molecular docking and dynamics simulation

F. Alhumaydhi, A. Atiya, W. Abdulmonem, 2023, Molecular diversity.

Structure-Based Identification of Natural Compounds as Potential RET-Kinase Inhibitors for Therapeutic Targeting of Neurodegenerative Diseases.

G. Hasan, S. Sohal, Manzar Alam, 2023, Journal of Alzheimer's disease : JAD.

Investigating molecular interactions between human transferrin and resveratrol through a unified experimental and computational approach: Role of natural compounds in Alzheimer’s disease therapeutics

Saleha Anwar, Dr Mohammad Furkan, D. K. Yadav, 2023, Amino acids.

Implication of Caffeic Acid for the Prevention and Treatment of Alzheimer's Disease: Understanding the Binding with Human Transferrin Using In Silico and In Vitro Approaches.

Debarati Das Gupta, Anas Shamsi, Moyad Shahwan, 2023, Molecular neurobiology.

Molecular and functional insight into focal adhesion kinases: Therapeutic implications for oral malignancies.

Anas Shamsi, Moyad Shahwan, Prathibha Prasad, 2023, Drug discovery today.

Elucidating the Impact of Deleterious Mutations on IGHG1 and Their Association with Huntington’s Disease

F. Anjum, Alaa Shafie, M. Hassan, 2024, Journal of personalized medicine.

Identifying repurposed drugs as potential inhibitors of Apolipoprotein E: A bioinformatics approach to target complex diseases associated with lipid metabolism and neurodegeneration.

Saleha Anwar, Nageeb Hassan, Dr Mohammad Furkan, 2024, International journal of biological macromolecules.

Targeting Sirtuin 1 for therapeutic potential: Drug repurposing approach integrating docking and molecular dynamics simulations

A. Alsayari, F. Alhumaydhi, Saleha Anwar, 2023, PloS one.

Unveiling Phytoconstituents with Inhibitory Potential Against Tyrosine-Protein Kinase Fyn: A Comprehensive Virtual Screening Approach Targeting Alzheimer's Disease.

Talal A. Zari, F. Alhumaydhi, Saleha Anwar, 2023, Journal of Alzheimer's disease : JAD.

Phytoconstituents as potential therapeutic agents against COVID-19: a computational study on inhibition of SARS-CoV-2 main protease.

Anas Shamsi, Moyad Shahwan, Abdullah Alsrhani, 2023, Journal of biomolecular structure & dynamics.

Unveiling promising inhibitors of superoxide dismutase 1 (SOD1) for therapeutic interventions.

F. Alhumaydhi, A. B. Muhsinah, M. Aljasir, 2023, International journal of biological macromolecules.

Phytocompounds targeting epigenetic modulations: an assessment in cancer

Sheersh Massey, Z. Malik, R. Parveen, 2024, Frontiers in pharmacology.

Identification of mitogen‐activated protein kinase 7 inhibitors from natural products: Combined virtual screening and dynamic simulation studies

Talha Jawaid, Hassan H. Alhassan, D. K. Yadav, 2023, Journal of molecular recognition : JMR.

Computational and spectroscopic insight into the binding of citral with human transferrin: Targeting neurodegenerative diseases

Dr Mohammad Furkan, D. K. Yadav, Anas Shamsi, 2024, Heliyon.

Investigating underlying molecular mechanisms, signaling pathways, emerging therapeutic approaches in pancreatic cancer

Imtaiyaz Hassan, G. Hasan, Mudassir Alam, 2024, Frontiers in oncology.

Comprehensive Insights into Biological Roles of Rosmarinic Acid: Implications in Diabetes, Cancer and Neurodegenerative Diseases

A. Islam, Saleha Anwar, G. Hasan, 2023, Nutrients.

Evaluation of the Binding Mechanism of Dietary Phytochemical, Ellagic Acid, with Human Transferrin: Spectroscopic, Calorimetric, and Computational Approaches Targeting Neurodegenerative Diseases

F. Alhumaydhi, Dr Mohammad Furkan, M. Alrouji, 2024, ACS omega.

Experimental and Computational Insights into the Molecular Interactions between Human Transferrin and Apigenin: Implications of Natural Compounds in Targeting Neuroinflammation

Saleha Anwar, D. K. Yadav, Anas Shamsi, 2023, ACS omega.

Unveiling the Molecular Interactions Between Human Transferrin and Limonene: Natural Compounds in Alzheimer’s Disease Therapeutics

F. Alhumaydhi, Dr Mohammad Furkan, M. Alrouji, 2024, Journal of Alzheimer's Disease.

Structure-based drug-development study against fibroblast growth factor receptor 2: molecular docking and Molecular dynamics simulation approaches

Dr Mohammad Furkan, D. K. Yadav, Anas Shamsi, 2024, Scientific reports.

ROS1 kinase inhibition reimagined: identifying repurposed drug via virtual screening and molecular dynamics simulations for cancer therapeutics

F. Alhumaydhi, M. Alrouji, S. Sharaf, 2024, Frontiers in chemistry.

Structure-based screening of FDA-approved drugs identifies potential histone deacetylase 3 repurposed inhibitor: molecular docking and molecular dynamic simulation approaches

D. K. Yadav, Anas Shamsi, Moyad Shahwan, 2024, Frontiers in pharmacology.

Understanding the interactions between repurposed drugs sertindole and temoporfin with receptor for advanced glycation endproducts: Therapeutic implications in cancer and metabolic diseases.

Saleha Anwar, D. K. Yadav, Anas Shamsi, 2024, Journal of molecular modeling.

Comprehensive spectroscopic and computational insight into the binding of vanillin with human transferrin: targeting neuroinflammation in Alzheimer’s disease therapeutics

F. Alhumaydhi, Dr Mohammad Furkan, M. Alrouji, 2024, Frontiers in pharmacology.

Unlocking therapeutic potential: computational insights into TREM2 protein targeting with FDA-approved drugs for neurodegeneration.

F. Alhumaydhi, M. Alrouji, S. Sharaf, 2024, Journal of biomolecular structure & dynamics.

Targeting PDE4A for therapeutic potential: exploiting drug repurposing approach through virtual screening and molecular dynamics.

Nageeb Hassan, N. Altwaijry, D. K. Yadav, 2024, Journal of biomolecular structure & dynamics.

Identifying Phosphodiesterase‐5 Inhibitors with Drug Repurposing Approach: Implications in Vasodysfunctional Disorders

Saleha Anwar, D. K. Yadav, Anas Shamsi, 2023, ChemistryOpen.

Pharmacological Features and Therapeutic Implications of Plumbagin in Cancer and Metabolic Disorders: A Narrative Review

G. Hasan, Chitra Dhiman, Anas Shamsi, 2024, Nutrients.

Investigating Pyruvate Dehydrogenase Kinase 3 Inhibitory Potential of Myricetin Using Integrated Computational and Spectroscopic Approaches

M. Alajmi, Saleha Anwar, M. Hassan, 2024, ACS omega.